| 1 | SELLAS Life Sciences Group, Inc.SLS | 60.4% | 11.51USD-0.69% |
| 2 | Novo Nordisk A/S Sponsored ADRNVO | 61.7% | 38.31USD-1.03% |
| 3 | Eli Lilly and CompanyLLY | 96.9% | 1,184.63USD-0.01% |
| 4 | Hims & Hers Health, Inc.HIMS | 88.8% | 28.70USD-0.28% |
| 5 | Iovance Biotherapeutics Inc.IOVA | 91.5% | 14.45USD+31.5% |
| 6 | Viking Therapeutics, Inc.VKTX | 78.3% | 31.81USD-3.69% |
| 7 | ImmunityBio Inc.IBRX | 86.4% | 8.83USD+3.64% |
| 8 | AbCellera Biologics Inc.ABCL | 89.6% | 14.82USD+6.47% |
| 9 | Moderna Inc.MRNA | 74.4% | 203.46USD+3.13% |
| 10 | Shoulder Innovations, Inc.SI | 74.2% | 18.79USD+4.68% |
| 11 | Capricor Therapeutics, Inc.CAPR | 76% | 8.57USD-1.61% |
| 12 | Tilray Brands Inc.TLRY | 77.9% | 3.95USD-1.74% |
| 13 | Jaguar Health, Inc.JAGX | 72.1% | 5.32USD-11.6% |
| 14 | Oscar Health, Inc.OSCR | 84.8% | 29.77USD+0.4% |
| 15 | Clover Health Investments, Corp. Class A Common StockCLOV | 62.6% | 4.33USD-0.12% |
| 16 | Nektar TherapeuticsNKTR | 57.9% | 59.24USD-1.92% |
| 17 | Kodiak Sciences Inc.KOD | 50.7% | 91.12USD+1.33% |
| 18 | Altimmune, Inc.ALT | 64% | 2.97USD+0.34% |
| 19 | Hinge Health Inc.HNGE | 99.1% | 95.21USD+2.99% |
| 20 | Biomea Fusion Inc.BMEA | 64.3% | 1.26USD-2.33% |
| 21 | Solid Biosciences Inc.SLDB | 0% | 7.16USD-1.65% |
| 22 | Abivax SAABVX | 37.5% | 98.50USD+1.7% |
| 23 | Tempus AI Inc Class A Common StockTEM | 96.6% | 82.58USD-2.94% |
| 24 | Tonix Pharmaceuticals Holding CorpTNXP | 71.3% | 9.65USD-2.53% |
| 25 | Novavax Inc.NVAX | 76.1% | 10.82USD+0.19% |
| 26 | AbbVie Inc.ABBV | 97% | 263.29USD-1.12% |
| 27 | Nautilus Biotechnology, Inc.NAUT | 99.4% | 1.37USD+23% |
| 28 | Artelo Biosciences, Inc.ARTL | 83.1% | 4.07USD-5.35% |
| 29 | Pfizer Inc.PFE | 92.9% | 28.72USD0% |
| 30 | Johnson & JohnsonJNJ | 94.3% | 267.57USD-1.61% |
| 31 | Vistagen Therapeutics Inc.VTGN | 86% | 0.30USD0% |
| 32 | Ocugen Inc.OCGN | 65.8% | 1.09USD+5.83% |
| 33 | Natera, Inc.NTRA | 99.3% | 414.52USD+0.67% |
| 34 | Prime Medicine, Inc.PRME | 75.1% | 3.09USD+7.48% |
| 35 | Twist Bioscience CorporationTWST | 78.1% | 186.13USD+3.64% |
| 36 | Summit Therapeutics Inc.SMMT | 84.6% | 16.39USD+5.88% |
| 37 | Merck & Co., Inc.MRK | 42.5% | 149.28USD+0.4% |
| 38 | Canopy Growth CorporationCGC | 72% | 0.93USD0% |
| 39 | Accuray IncorporatedARAY | 93.2% | 0.30USD0% |
| 40 | UnitedHealth Group IncorporatedUNH | 79.3% | 374.94USD-0.76% |
| 41 | Intuitive Surgical Inc.ISRG | 71.2% | 412.18USD-0.63% |
| 42 | Boston Scientific Corp.BSX | 84.8% | 43.88USD-0.52% |
| 43 | 10x Genomics Inc. Class A Common StockTXG | 99.8% | 90.04USD+1.74% |
| 44 | uniQure N.V.QURE | 50.3% | 24.51USD-37.3% |
| 45 | GlucoTrack Inc.GCTK | 59.1% | 1.74USD-3.33% |
| 46 | Guardant Health Inc.GH | 100% | 177.73USD+0.23% |
| 47 | Onconetix Inc.ONCO | 76.5% | 0.82USD-26.1% |
| 48 | United Therapeutics CorporationUTHR | 5.81% | 481.47USD-0.84% |
| 49 | Candel Therapeutics, Inc.CADL | 85% | 10.88USD-2.77% |
| 50 | Novartis AG Sponsored ADRNVS | 84.9% | 145.71USD-0.8% |
| 51 | GRAIL, Inc.GRAL | 97% | 136.57USD+2.97% |
| 52 | Compass Pathways plc - ADRCMPS | 81.5% | 12.96USD-2.04% |
| 53 | Recursion Pharmaceuticals, Inc. Class A Common StockRXRX | 83.5% | 4.03USD+8.92% |
| 54 | PDS Biotechnology CorporationPDSB | 80.4% | 0.74USD-3% |
| 55 | MannKind CorporationMNKD | 68.2% | 3.34USD-0.3% |
| 56 | BullFrog AI Holdings, Inc.BFRG | 88.8% | 0.65USD-1.37% |
| 57 | Ocular Therapeutix, Inc.OCUL | 52.4% | 7.87USD+2.81% |
| 58 | High Tide Inc.HITI | 94.4% | 2.80USD-0.36% |
| 59 | Ginkgo Bioworks Holdings, Inc. Class A Common StockDNA | 49% | 11.96USD+14.3% |
| 60 | TG Therapeutics Inc.TGTX | 91.1% | 56.19USD0% |
| 61 | Cosmos Health Inc.COSM | 82.3% | 0.42USD+13.8% |
| 62 | CVS Health CorporationCVS | 99.5% | 87.10USD-0.85% |
| 63 | CRISPR Therapeutics AGCRSP | 91.3% | 56.00USD+3.53% |
| 64 | Xeris Biopharma Holdings, Inc.XERS | 95.2% | 9.98USD+1.53% |
| 65 | Gain Therapeutics, Inc.GANX | 79.3% | 1.68USD-5.08% |
| 66 | Abbott LaboratoriesABT | 100% | 100.95USD-0.03% |
| 67 | Insulet CorporationPODD | 66.7% | 132.84USD-0.2% |
| 68 | Amgen Inc.AMGN | 98.5% | 423.64USD+1.32% |
| 69 | Schrödinger, Inc.SDGR | 89.9% | 30.33USD+2.81% |
| 70 | Revolution Medicines, Inc.RVMD | 98.7% | 204.48USD+1.36% |
| 71 | Beta Bionics, Inc. Common StockBBNX | 100% | 19.41USD-5.41% |
| 72 | Tandem Diabetes Care, Inc.TNDM | 0% | 16.57USD+0.91% |
| 73 | Zoetis Inc. Class A Common StockZTS | 14% | 70.30USD-1.58% |
| 74 | ClearPoint Neuro Inc.CLPT | 87.5% | 11.77USD-23.1% |
| 75 | Madrigal Pharmaceuticals Inc.MDGL | 93.6% | 509.44USD-1.47% |
| 76 | Gilead Sciences, Inc.GILD | 98% | 151.28USD-0.61% |
| 77 | Silexion Therapeutics Corp.SLXN | 85.7% | 0.32USD+28.2% |
| 78 | IM Cannabis Corp.IMCC | 69.6% | 2.45USD-1.21% |
| 79 | Liquidia CorporationLQDA | 47.1% | 70.69USD-4.05% |
| 80 | BridgeBio Pharma Inc.BBIO | 32.5% | 65.97USD-0.96% |
| 81 | Healthcare Triangle Inc.HCTI | 70.8% | 0.66USD-11.7% |
| 82 | TransMedics Group, Inc.TMDX | 100% | 84.07USD+1.62% |
| 83 | Sarepta Therapeutics, Inc.SRPT | 79.1% | 18.64USD-0.85% |
| 84 | Anavex Life Sciences CorpAVXL | 6.58% | 2.36USD+0.43% |
| 85 | MultiPlan CorporationCTEV | 0% | 21.64USD-3.69% |
| 86 | Illumina Inc.ILMN | 85% | 272.00USD+0.04% |
| 87 | Agilent Technologies Inc.A | 0% | 175.03USD-0.1% |
| 88 | Tenet Healthcare Corp.THC | 0% | 257.60USD-0.13% |
| 89 | Outlook Therapeutics Inc.OTLK | 70.1% | 0.63USD+0.81% |
| 90 | Axsome Therapeutics IncAXSM | 66.4% | 186.14USD-4% |
| 91 | Matinas BioPharma Holdings, Inc.MTNB | 97.6% | 2.88USD+13.8% |
| 92 | Humana Inc.HUM | 100% | 386.87USD-0.71% |
| 93 | Ardelyx IncARDX | 60.8% | 3.39USD-0.59% |
| 94 | CareDx IncCDNA | 95.4% | 64.02USD-0.9% |
| 95 | Arcturus Therapeutics Holdings Inc.ARCT | 94.1% | 13.70USD-5.26% |
| 96 | Genprex Inc. Common StockGNPX | 80% | 2.85USD+1.42% |
| 97 | Aurora Cannabis Inc.ACB | 77.4% | 4.03USD-1.47% |
| 98 | Cue Biopharma, Inc.CUE | 46% | 25.51USD-7.07% |
| 99 | Akebia Therapeutics Inc.AKBA | 39.6% | 0.89USD-0.78% |
| 100 | Veeva Systems Inc.VEEV | 97.4% | 278.57USD-0.5% |